Total trials
100
Active
22
Phase 3
12
Total enrollment
88,974
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Colchicine | — | — | — | — | 6 | ||
| colchicine placebo | — | — | — | — | — | 2 | |
| Prescription of Aspirin | — | — | — | — | — | 1 | |
| No prescription | — | — | — | — | — | 1 | |
| Aspirin | — | — | — | — | — | 1 | |
| Aspirin Placebo | — | — | — | — | — | 1 | |
| Ticagrelor + placebo | — | — | — | — | — | 1 | |
| Ticagrelor + aspirin | — | — | — | — | — | 1 | |
| Combined Epoprostenol Sodium & Milrinone | — | — | — | — | — | 1 | |
| Normal saline | — | — | — | — | — | 1 | |
| Aspirin 81Mg Ec Tab twice daily for 7 days | — | — | — | — | — | 1 | |
| Aspirin 40Mg Chew Tab twice daily for 7 days | — | — | — | — | — | 1 | |
| Aspirin 162 mg EC Tab once daily for 7 days | — | — | — | — | — | 1 | |
| Aspirin 80 mg EC Tab | — | — | — | — | — | 1 |
Next readouts
- 2024-04-01
- 2027-05-01
- 2027-06-01
- 2027-12
- 2028-05-01
- 2030-01-01
Top conditions
- Heart Failure12
- Coronary Artery Disease9
- Atrial Fibrillation5
- Right Heart Failure5
- Acute Coronary Syndrome4
- Myocardial Infarction4
- Congestive Heart Failure4
- Coronary Heart Disease4
Frequently asked questions about Montreal Heart Institute
- How many clinical trials does Montreal Heart Institute have on ClinicalTrials.gov?
- Montreal Heart Institute is listed as the lead sponsor on 100 clinical trials in ClinicalTrials.gov, 22 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Montreal Heart Institute's trials are in Phase 3?
- 12 of Montreal Heart Institute's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does Montreal Heart Institute focus on?
- Montreal Heart Institute's most-studied conditions on ClinicalTrials.gov are Heart Failure, Coronary Artery Disease, Atrial Fibrillation, Right Heart Failure, Acute Coronary Syndrome.
- When are Montreal Heart Institute's next clinical trial readouts?
- Montreal Heart Institute has 6 upcoming primary-completion readouts tracked here; the soonest is “Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes”, expected around 2024-04-01.